The profitability of UGI CORPORATION over the past 10 years
Chart UGI CORPORATION: operating income, net income, fiscal 2016–2025 Open the chart →UGI CORPORATION reported net income of $678M in fiscal 2025, the latest fiscal year on file. That year it had operating income of $1.11B. It reported a profit in 9 of the 10 years shown, and a loss in fiscal 2023. Its highest net income in these years was $1.47B, in fiscal 2021.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Sep 30, 2025 | $1.11B | $678M |
| 2024ended Sep 30, 2024 | $770M | $269M |
| 2023ended Sep 30, 2023 | -$1.44B | -$1.5B |
| 2022ended Sep 30, 2022 | $1.67B | $1.07B |
| 2021ended Sep 30, 2021 | $2.35B | $1.47B |
| 2020ended Sep 30, 2020 | $982M | $532M |
| 2019ended Sep 30, 2019 | $617M | $256M |
| 2018ended Sep 30, 2018 | $1.06B | $719M |
| 2017ended Sep 30, 2017 | $1.01B | $436.6M |
| 2016ended Sep 30, 2016 | $988M | $364.7M |
Fiscal years as UGI CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on UGI CORPORATION
- The revenue of UGI CORPORATION
- The cash flow of UGI CORPORATION
- The debt of UGI CORPORATION
- The dividends of UGI CORPORATION
- All of UGI CORPORATION's financials, charted
Companies of a similar size
- WLKWestlake Corporation
- LEVILEVI STRAUSS & CO
- ADCAGREE REALTY CORPORATION
- ZWSZURN ELKAY WATER SOLUTIONS CORPORATION
- ARWRARROWHEAD PHARMACEUTICALS, INC.
Not investment advice. This page shows what UGI CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.